[Treatment of epicondylitis with locally injected orgotein (double blind study)].
The efficacy of locally injected orgotein in epicondylitis was investigated in a double-blind clinical trial. The results of the previously used method of treatment--injection with procaine hydrochloride--were applied as a comparison. In nearly all cases of acute epicondylitis, improvement was seen after orgotein injections. More than 70% of these patients were symptom-free 6 weeks after beginning therapy, a result significantly superior to that of the compared method. Both regimens produced distinctly less favorable results in chronic epicondylitis. In acute epicondylitis orgotein may be regarded as an alternative to the more common and potentially risky corticoid therapy.
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007270:Injections, Intra-Articular; D008297:Male; D008667:Metalloproteins / Q000627:therapeutic use*; D013716:Tennis Elbow / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D008667:Metalloproteins; C005180:orgotein
Uber die Behandlung der Epicondylitis mit lokal injiziertem Orgotein (Doppelblindstudie).